TrialBlood2011

High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.

Thomas S Uldrick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.